The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 07, 2014
Filed:
Jan. 13, 2012
Hisashi Narimatsu, Ibaraki, JP;
Yuzuru Ikehara, Ibaraki, JP;
Atsushi Kuno, Ibaraki, JP;
Maki Sogabe, Ibaraki, JP;
Yasuhito Tanaka, Aichi, JP;
Masashi Mizokami, Chiba, JP;
Kiyoaki Ito, Chiba, JP;
Shunsuke Matsubara, Hyogo, JP;
Chikayuki Tsuruno, Hyogo, JP;
Youichi Takahama, Hyogo, JP;
Takashi Kagawa, Hyogo, JP;
Shinya Nagai, Hyogo, JP;
Hisashi Narimatsu, Ibaraki, JP;
Yuzuru Ikehara, Ibaraki, JP;
Atsushi Kuno, Ibaraki, JP;
Maki Sogabe, Ibaraki, JP;
Yasuhito Tanaka, Aichi, JP;
Masashi Mizokami, Chiba, JP;
Kiyoaki Ito, Chiba, JP;
Shunsuke Matsubara, Hyogo, JP;
Chikayuki Tsuruno, Hyogo, JP;
Youichi Takahama, Hyogo, JP;
Takashi Kagawa, Hyogo, JP;
Shinya Nagai, Hyogo, JP;
Sysmex Corporation, Hyogo, JP;
National Institute of Advanced Industrial Science and Technology, Tokyo, JP;
Nagoya University, Aichi, JP;
National Center for Global Health and Medicine, Tokyo, JP;
Abstract
An object of the present invention is to provide a method for measuring a glycan-marker glycoprotein, by which liver disease can be detected with higher accuracy than is possible with conventional methods. Also, an object of the present invention is to provide a method for examining liver disease, by which liver disease can be detected with higher accuracy than is possible with conventional methods. Disclosed is a method for measuring at least one glycoprotein selected from alpha-1-acid glycoprotein (AGP) and Mac-2-binding protein (M2BP) contained in a sample collected from a subject, comprising: measuring AGP binding to a first lectin selected from AOL and MAL, when the glycoprotein is AGP; and measuring M2BP binding to a second lectin selected from WFA, BPL, AAL, RCA120, and TJAII, when the glycoprotein is M2BP.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile